Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
暂无分享，去创建一个
M. Kurosaki | N. Izumi | T. Sohda | H. Yoshida | J. Itakura | Y. Kojima | K. Tsuji | K. Joko | A. Nasu | A. Kusakabe | H. Kimura | H. Kobashi | T. Akahane | Chikara Ogawa | C. Hasebe | T. Abe | Y. Uchida | S. Wada | Takashi Tamada | A. Mitsuda | A. Morita | M. Kondo | Hideyuki Suzuki | Masaya Shigeno | Y. Ide | Tadashi Kitamura | C. Ogawa | Akihiro Nasu